Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1108

    1.

    Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.

    van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH, Kastelein JJ, Khaw KT.

    Ann Intern Med. 2007 May 1;146(9):640-8.PMID: 17470832 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.

    Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS.

    JAMA. 2007 Aug 15;298(7):776-85.PMID: 17699011 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.

    Kim HK, Chang SA, Choi EK, Kim YJ, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS.

    Int J Cardiol. 2005 Jun 8;101(3):435-40.PMID: 15907412 [PubMed - indexed for MEDLINE]Related articles

    4.

    High-density lipoprotein particle size and concentration and coronary risk.

    El Harchaoui K, Arsenault BJ, Franssen R, Després JP, Hovingh GK, Stroes ES, Otvos JD, Wareham NJ, Kastelein JJ, Khaw KT, Boekholdt SM.

    Ann Intern Med. 2009 Jan 20;150(2):84-93.PMID: 19153411 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction.

    Goswami B, Rajappa M, Mallika V, Kumar S, Shukla DK.

    Acta Cardiol. 2008 Dec;63(6):749-55.PMID: 19157171 [PubMed - indexed for MEDLINE]Related articles

    6.

    Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

    El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM.

    J Am Coll Cardiol. 2007 Feb 6;49(5):547-53. Epub 2007 Jan 22.PMID: 17276177 [PubMed - indexed for MEDLINE]Related articles

    7.

    Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.

    Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F.

    Atherosclerosis. 2002 Jun;162(2):381-9.PMID: 11996958 [PubMed - indexed for MEDLINE]Related articles

    8.

    The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.

    Rasouli M, Kiasari AM, Mokhberi V.

    Clin Chem Lab Med. 2006;44(8):1015-21.PMID: 16879071 [PubMed - indexed for MEDLINE]Related articles

    9.

    Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.

    Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM.

    J Am Coll Cardiol. 2007 Jul 10;50(2):159-65. Epub 2007 Jun 21.PMID: 17616301 [PubMed - indexed for MEDLINE]Related articles

    10.

    High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.

    van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ES, Tikkanen MJ, Wareham NJ, Faergeman O, Olsson AG, Pedersen TR, Khaw KT, Kastelein JJ.

    J Am Coll Cardiol. 2008 Feb 12;51(6):634-42.PMID: 18261682 [PubMed - indexed for MEDLINE]Related articles

    12.

    Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.

    Keller TT, Choi D, Nagel C, Te Velthuis H, Gerdes VE, Wareham NJ, Bingham SA, Luben R, Hack CE, Reitsma PH, Levi M, Khaw KT, Boekholdt SM.

    J Thromb Haemost. 2006 Nov;4(11):2391-6. Epub 2006 Aug 28. Erratum in: J Thromb Haemost. 2006 Dec;4(12):2742. Choi, D [added]. PMID: 16938131 [PubMed - indexed for MEDLINE]Related articles

    13.

    Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.

    Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM.

    Circulation. 2007 Oct 30;116(18):2029-35. Epub 2007 Oct 8.PMID: 17923573 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.

    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J Jr.

    Can J Cardiol. 1997 Mar;13(3):253-60.PMID: 9117913 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.

    Boekholdt SM, Kuivenhoven JA, Wareham NJ, Peters RJ, Jukema JW, Luben R, Bingham SA, Day NE, Kastelein JJ, Khaw KT.

    Circulation. 2004 Sep 14;110(11):1418-23. Epub 2004 Aug 30.PMID: 15337694 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.

    Jadhav UM, Kadam NN.

    J Assoc Physicians India. 2004 May;52:370-5.PMID: 15656025 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.

    Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JN, Hutten BA, Kastelein JJ, Kuivenhoven JA, Khaw KT, Boekholdt SM.

    Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):637-42. Epub 2005 Dec 22.PMID: 16373616 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

    Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE.

    JAMA. 2005 Jul 20;294(3):326-33.PMID: 16030277 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.

    Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J, Walldius G, Hellenius ML, Hamsten A.

    Eur Heart J. 2009 Mar;30(6):710-7. Epub 2008 Aug 1.PMID: 18676970 [PubMed - indexed for MEDLINE]Related articles

    20.

    Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.

    Azizi F, Rahmani M, Raiszadeh F, Solati M, Navab M.

    Coron Artery Dis. 2002 Feb;13(1):9-16.PMID: 11917194 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data